Ad
ATRS Quote Trading Chart Antares Pharma Inc.
home / stock / atrs / atrs quote
$5.59 Last:
0.0% Change Percent:
$5.58 Open:
$5.59 Previous Close:
$5.6 High:
$5.58 Low:
2,703,913 Volume:
05/23/2022 04:53:25 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ATRS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-05-23 | 5.58 | 5.59 | 5.6 | 5.58 | 2,703,913 |
| 2022-05-20 | 5.585 | 5.59 | 5.59 | 5.58 | 1,763,397 |
| 2022-05-19 | 5.58 | 5.58 | 5.59 | 5.58 | 2,602,120 |
| 2022-05-18 | 5.57 | 5.58 | 5.58 | 5.57 | 1,346,970 |
| 2022-05-17 | 5.58 | 5.58 | 5.58 | 5.57 | 1,412,639 |
| 2022-05-16 | 5.575 | 5.57 | 5.58 | 5.57 | 1,594,921 |
| 2022-05-13 | 5.56 | 5.57 | 5.58 | 5.56 | 1,829,525 |
| 2022-05-12 | 5.57 | 5.57 | 5.58 | 5.54 | 7,110,900 |
| 2022-05-11 | 5.56 | 5.56 | 5.57 | 5.56 | 3,333,808 |
| 2022-05-10 | 5.57 | 5.56 | 5.57 | 5.55 | 3,244,656 |
| 2022-05-09 | 5.56 | 5.56 | 5.57 | 5.56 | 2,632,734 |
| 2022-05-06 | 5.57 | 5.56 | 5.58 | 5.56 | 2,332,651 |
| 2022-05-05 | 5.58 | 5.56 | 5.5899 | 5.56 | 4,898,523 |
| 2022-05-04 | 5.59 | 5.59 | 5.59 | 5.57 | 3,300,536 |
| 2022-05-03 | 5.58 | 5.59 | 5.59 | 5.57 | 3,269,450 |
| 2022-05-02 | 5.56 | 5.59 | 5.59 | 5.56 | 6,496,354 |
| 2022-04-29 | 5.56 | 5.565 | 5.57 | 5.56 | 6,489,231 |
| 2022-04-28 | 5.57 | 5.56 | 5.57 | 5.56 | 5,891,201 |
| 2022-04-27 | 5.56 | 5.57 | 5.57 | 5.56 | 6,955,027 |
| 2022-04-26 | 5.57 | 5.56 | 5.57 | 5.56 | 8,454,904 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma PR Newswire SAN DIEGO , May 12, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (" Halozyme ") today announced that the waiting period unde...
-
Antares Pharma Inc shares ( NASDAQ: ATRS ) are up 45% on Wednesday after Halozyme Therapeutics said it will buy the New Jersey-headquartered company for $960 million in cash. Details of the agreement The deal translates to $5.60 per share for Antares Pharma shareholders that...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Late-stage biopharmaceutical company Sierra Oncology (NASDAQ: SRRA ) is up big today on news that GlaxoSmithKline (NYSE: GSK ) will purchase the business . Indeed, SRRA stock is up a massive 38% so far today on...